These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 5135008)

  • 1. [Treatment of primary and secondary Raynaud's syndrome using naftidrofuryl (Dusodril)].
    Kriessmann A; Sauer E
    Dtsch Med J; 1971 Dec; 22(23):743-5. PubMed ID: 5135008
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of functional changes in arteriosclerotic chronic obliterating peripheral arterial diseases (COPA) and Buerger's and Raynaud's diseases with pharmacological sympathicolysis, with or without indirect surgical treatment].
    Bagliani A; Borri P; Taborelli R
    Minerva Cardioangiol; 1973 Jun; 21(6):439-52. PubMed ID: 4720185
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes of lower leg blood circulation during oral therapy with naftidrofuryl (dusodril)].
    Kriessmann A; Rädler M
    Munch Med Wochenschr; 1973 Mar; 115(12):508-10. PubMed ID: 4739661
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experience with the new vasoactivator Dusodril. Results of clinical tests and a double-blind experiment].
    Bötticher R; Raithel D
    Med Klin; 1971 Nov; 66(46):1571-3. PubMed ID: 4944892
    [No Abstract]   [Full Text] [Related]  

  • 5. [Naphthydrofuryl in neurology].
    Ahumada BH
    Prensa Med Argent; 1971 Jul; 58(21):1067-70. PubMed ID: 5096690
    [No Abstract]   [Full Text] [Related]  

  • 6. [Vasodilator agents in peripheral arterial occlusive disease with coronary insufficiency, myocardial infarct and pacemakers. Electrocardiographic studies in intravenous naftidrofuryl-infusion].
    Heidrich H; Wehselau H
    Med Welt; 1974 Jul; 25(26):1161-3. PubMed ID: 4845152
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical experiences with naftidrofuryl in peripheral arterial occlusive diseases].
    Hauch E; Lévai Z
    Med Welt; 1973 Oct; 24(43):1665-6. PubMed ID: 4764064
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic results in peripheral and cerebrovascular blood circulation disorders following the administration of Dusodril].
    Kaufmann J; Förster W
    Z Allgemeinmed; 1970 May; 46(13):688-9. PubMed ID: 5522940
    [No Abstract]   [Full Text] [Related]  

  • 9. [Angiodilatator therapy in otology: value of Praxilene].
    Bordes LR; Baradat P; Lienhart H; Debrie JC
    Rev Laryngol Otol Rhinol (Bord); 1971; 92(11):858-63. PubMed ID: 5151167
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapy of arterial occlusive diseases with Dusodril].
    Fortschr Med; 1974 Jul; 92(20):873-4. PubMed ID: 4411256
    [No Abstract]   [Full Text] [Related]  

  • 11. Double-blind trial of naftidrofuryl in the treatment of cerebral arteriosclerosis.
    Gerin J
    Br J Clin Pract; 1974 May; 28(5):177-8. PubMed ID: 4604345
    [No Abstract]   [Full Text] [Related]  

  • 12. Pulse cyclophosphamide decreases sympathetic postganglionic activity, controls alveolitis, and normalizes vascular tone dysfunction (Raynaud's phenomenon) in a case of early systemic sclerosis.
    Casale R; Generini S; Luppi F; Pignone A; Matucci-Cerinic M
    Arthritis Rheum; 2004 Aug; 51(4):665-9. PubMed ID: 15334442
    [No Abstract]   [Full Text] [Related]  

  • 13. Laser Doppler-recorded venoarteriolar reflex in Raynaud's phenomenon.
    Stoyneva Z
    Auton Neurosci; 2004 Nov; 116(1-2):62-8. PubMed ID: 15556839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Naftidrofuryl in venous pathology].
    Milleret PG
    Phlebologie; 1970; 23(2):189-91. PubMed ID: 5448640
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of naftidrofuryl on microcirculatory cold sensitivity in Raynaud's phenomenon.
    Nilsen KH
    Br Med J; 1979 Jan; 1(6155):20-1. PubMed ID: 367494
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiovascular responses evoked by mild cool stimuli in primary Raynaud's disease: the role of endothelin.
    Edwards CM; Marshall JM; Pugh M
    Clin Sci (Lond); 1999 Jun; 96(6):577-88. PubMed ID: 10334963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of sympathetic reactivity in the development of Raynaud's syndrome].
    Shcherbakov AB; Guseva NG; Mach ZS
    Ter Arkh; 1993; 65(5):22-5. PubMed ID: 8036589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of Raynaud's phenomenon by methyldopa.
    Varadi DP; Lawrence AM
    Arch Intern Med; 1969 Jul; 124(1):13-8. PubMed ID: 5791479
    [No Abstract]   [Full Text] [Related]  

  • 19. [Value of vasodilator agents in neuropsychiatric practice and study of the indications for Praxilene].
    Bornstein S; Sère de Rivières H
    Therapeutique; 1972 Jan; 48(1):27-34. PubMed ID: 5046366
    [No Abstract]   [Full Text] [Related]  

  • 20. [Naftidrofuryl, a new blood vessel-active substance in the preparation for arterial vascular surgery].
    Becker HM
    Med Klin; 1970 Feb; 65(8):359-61. PubMed ID: 5519232
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.